| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3846629 | Advances in Chronic Kidney Disease | 2014 | 8 Pages |
Abstract
APOL1 kidney disease is a unique case in the field of the genetics of common disease: 2 variants (termed G1 and G2) with high population frequency have been repeatedly associated with nondiabetic CKDs, with very strong effect size (odds ratios 3-29) in populations of sub-Saharan African descent. This review provides an update on the spectrum of APOL1 kidney disease and on the worldwide distribution of these kidney risk variants. We also summarize the proper way to run a recessive analysis on joint and independent effects of APOL1 G1 and G2 kidney risk variants.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Sophie Limou, George W. Nelson, Jeffrey B. Kopp, Cheryl A. Winkler,